The validity of serologic tests for <i>Trypanosoma cruzi</i> and the effectiveness of transfusional screening strategies in a hyperendemic region

Simple item page
dc.contributor.authorMarianne Pirard
dc.contributor.authorNaomi Iihoshi
dc.contributor.authorMarleen Boelaert
dc.contributor.authorPaulino Basanta
dc.contributor.authorFrancisco Gomez Lopez
dc.contributor.authorPatrick Van der Stuyft
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:03:23Z
dc.date.available2026-03-22T14:03:23Z
dc.date.issued2005
dc.descriptionCitaciones: 80
dc.description.abstractRoutine blood donor screening for T. cruzi with a single test results in unacceptable numbers of false-negative samples in highly endemic areas or in at risk population groups. Adding a second test seems mandatory, but which one to choose depends on local cost components and feasibility.
dc.identifier.doi10.1111/j.0041-1132.2005.04214.x
dc.identifier.urihttps://doi.org/10.1111/j.0041-1132.2005.04214.x
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/44281
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofTransfusion
dc.sourceInstituut voor Tropische Geneeskunde
dc.subjectMedicine
dc.subjectSerology
dc.subjectTrypanosoma cruzi
dc.subjectPopulation
dc.subjectChagas disease
dc.subjectImmunology
dc.titleThe validity of serologic tests for <i>Trypanosoma cruzi</i> and the effectiveness of transfusional screening strategies in a hyperendemic region
dc.typearticle

Files

Collections

Artículo Científico Publicado